This Article Full Text Full Text (PDF) All Versions of this Article: 91/7/2618    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mulatero, P. Articles by Maccario, M. Search for Related Content PubMed PubMed Citation Articles by Mulatero, P. Articles by Maccario, M. Related Collections Adrenal and Hypertension Endocrine Oncology

Comparison of Confirmatory Tests for the Diagnosis of Primary Aldosteronism

Division of Internal Medicine and Hypertension (P.M., A.M., F.V.), University of Torino, 10133 Torino, Italy; Division of Internal Medicine 3 (F.F.), University of Padova, 35128 Padova, Italy; Division of Internal Medicine (G.R.), Reggio Emilia Hospital, 42100 Reggio Emilia, Italy; Division of Internal Medicine B (F.P.), University of Verona, 37134 Verona, Italy; Division of Endocrinology (C.F., L.Mo.), P. Universitad Catolica de Chile, 114D Santiago, Chile; and Division of Endocrinology and Metabolism (L.Ma., F.V., M.M.), University of Torino, 10126 Torino, Italy

Address all correspondence and requests for reprints to: Paolo Mulatero, M.D., Centro Ipertensione Ospedale San Vito, Strada San Vito 34, 10133, Torino, Italy. E-mail: paolo.mulatero{at}libero.it.

Context: Primary aldosteronism (PA) is the most frequent form of secondary hypertension, accounting for up to 5–10% of all hypertensive patients, and the diagnosis of PA can present an important challenge for the clinician. After a positive screening test, the diagnosis is confirmed by a suppression test, often an iv saline load test (SLT) or a fludrocortisone suppression test (FST). The FST is considered by many to be the most reliable but is more complex and expensive.

Objective and Design: Our objective was to compare the specificity of SLT with FST for the diagnosis of PA.

Patients and Setting: The study included 100 hypertensive patients referred to hypertension units with suspected PA after the screening test.

Intervention: All patients underwent FST and SLT.

Main Outcome Measures: We assessed plasma aldosterone concentrations (PAC) before and after FST and SLT.

Results: After iv SLT, 10.4% of the PA patients were negative and 16.1% of patients with essential hypertension were positive after SLT; that is, a correct diagnosis with SLT was obtained in 88% of patients compared with FST. PAC after SLT and PAC after FST were highly correlated (P < 0.0001). Receiver operator characteristic curve analysis demonstrated that the best cutoff for PAC after SLT was 5 ng/dl. Patients with aldosterone-producing adenoma displayed a smaller reduction of PAC compared with patients with bilateral adrenal hyperplasia; a PAC after SLT greater than 6 ng/dl identified all patients eventually diagnosed as having aldosterone-producing adenoma.

Conclusions: This study demonstrates that the iv SLT is a reasonably good alternative to the more expensive and complex FST for the diagnosis of PA after a positive screening test.

This article has been cited by other articles:

				B Rayner Primary aldosteronism and aldosterone-associated hypertension J. Clin. Pathol., July 1, 2008; 61(7): 825 - 831. [Abstract] [Full Text] [PDF]

				P. Mulatero, C. Bertello, D. Rossato, G. Mengozzi, A. Milan, C. Garrone, G. Giraudo, G. Passarino, D. Garabello, A. Verhovez, et al. Roles of Clinical Criteria, Computed Tomography Scan, and Adrenal Vein Sampling in Differential Diagnosis of Primary Aldosteronism Subtypes J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1366 - 1371. [Abstract] [Full Text] [PDF]

				C. Catena, G. Colussi, E. Nadalini, A. Chiuch, S. Baroselli, R. Lapenna, and L. A. Sechi Cardiovascular Outcomes in Patients With Primary Aldosteronism After Treatment Arch Intern Med, January 14, 2008; 168(1): 80 - 85. [Abstract] [Full Text] [PDF]

				G. Mengozzi, D. Rossato, C. Bertello, C. Garrone, A. Milan, R. Pagni, F. Veglio, and P. Mulatero Rapid Cortisol Assay during Adrenal Vein Sampling in Patients with Primary Aldosteronism Clin. Chem., November 1, 2007; 53(11): 1968 - 1971. [Abstract] [Full Text] [PDF]

				P. Mulatero, C. Bertello, C. Garrone, D. Rossato, G. Mengozzi, A. Verhovez, F. Fallo, and F. Veglio Captopril Test Can Give Misleading Results in Patients With Suspect Primary Aldosteronism Hypertension, August 1, 2007; 50(2): e26 - e27. [Full Text] [PDF]

				G. P. Rossi, A. Belfiore, G. Bernini, G. Desideri, B. Fabris, C. Ferri, G. Giacchetti, C. Letizia, M. Maccario, F. Mallamaci, et al. Comparison of the Captopril and the Saline Infusion Test for Excluding Aldosterone-Producing Adenoma Hypertension, August 1, 2007; 50(2): 424 - 431. [Abstract] [Full Text] [PDF]

				S. J. Hood, K. P. Taylor, M. J. Ashby, and M. J. Brown The Spironolactone, Amiloride, Losartan, and Thiazide (SALT) Double-Blind Crossover Trial in Patients With Low-Renin Hypertension and Elevated Aldosterone-Renin Ratio Circulation, July 17, 2007; 116(3): 268 - 275. [Abstract] [Full Text] [PDF]

				C. Catena, G. Colussi, E. Nadalini, A. Chiuch, S. Baroselli, R. Lapenna, and L. A. Sechi Relationships of Plasma Renin Levels with Renal Function in Patients with Primary Aldosteronism Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 722 - 731. [Abstract] [Full Text] [PDF]